Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Stephens Investment Conference Transcript

Nov 17, 2022 / 03:00PM GMT
Release Date Price: $14.16 (-5.66%)
Jeff Garro;Stephens;Managing Director

All right. Welcome again to everyone to day 3 of the Stephens Investment Conference. I'm Jeff Garro, the healthcare IT analyst here at Stephens, and I'm very happy to welcome Andrew Schemick and Ron DiSantis, from Certara here to the conference. Andrew is the CFO; and Ron is the SVP of Corporate Development. So thanks again for joining us, guys. And I'll just jump right into the questions.

Questions & Answers

Jeff Garro;Stephens;Managing Director

And Andrew, I know some people in the audience might not know much more about Certara other than it's a leader in biosimulation. So I was hoping you could start us off with a high-level description of what biosimulation is and why it's an interesting and valuable tool for biopharma companies to deploy, and maybe to throw one more prompt in there, why Certara is viewed as a leader in the field?

Andrew Schemick
Certara, Inc. - CFO

Okay. Thank you. I appreciate the invitation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot